Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Preventing Heart Attacks and Strokes in High Need Areas is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The purpose of program is to support implementation of population-wide and priority population approaches to prevent and control high blood pressure, and reduce health disparities associated with high blood pressure, among adults in Mississippi's 18-county Delta Region, which is a high burden, underserved, rural area. This listing is currently active. Program number: 93.816. Last updated on 2026-01-12.
Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $3,500,000 (2026).; eligibility guidance Financial assistance from this listing will be provided only to the Mississippi Department of Health /Mississippi Delta Health Collaborative (MDHC). Eligible applicant types include: Other.
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Based on current listing details, eligibility includes: Financial assistance from this listing will be provided only to the Mississippi Department of Health /Mississippi Delta Health Collaborative (MDHC). Eligible applicant types include: Other. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Recent federal obligations suggest $3,500,000 (2026). Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Networking2Save”: CDC’s National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The Office on Smoking and Health and Division of Cancer Prevention and Control seek to build on the progress of the previously funded networks and expand work to address tobacco-and cancer- related health disparities among populations particularly vulnerable to tobacco industry marketing tactics and with higher cancer incidence and death rates. To accelerate the decline in cigarette smoking, address other tobacco use, and reduce the burden of cancer disease and death among the entire population, it will be critical to continue to focus prevention and control efforts on those populations that are most vulnerable and harder to reach with general population interventions. The complex interaction of multiple factors (e.g. socioeconomic status, cultural characteristics, acculturation, stress) and persistent and targeted tobacco industry marketing to these vulnerable populations, contribute to tobacco related disparities. Many factors also contribute to cancer-related disparities such as socioeconomic status, cultural characteristics, diet, and access to healthcare services. This listing is currently active. Program number: 93.431. Last updated on 2026-01-12. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $6,800,000 (2026).; eligibility guidance Open competition Eligible applicant types include: Unrestricted by Entity Type. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. CDC’s global health efforts are to assist Ministries of Health and other international partners to plan, effectively manage and conduct public health research in the intent of public health protection; achieve US Government program and international organization goals to improve health; including surveillance, intervention and prevention in global health programs that focus on leading causes of global health security, mortality, morbidity and disability including infectious diseases including bacterial, viral and parasitic diseases , non-communicable diseases, injury and violence, environmental health, generate and apply new knowledge to achieve public health goals and strengthen public health systems and capacity. This listing is currently active. Program number: 93.326. Last updated on 2026-01-21. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $12,000,000 (2026).; eligibility guidance Dependent on the Notice of Funding Opportunity (NOFO), eligibility may range from open, competitive, limited or single eligibility in accordance with authorizing legislation. May include non-profit organizations who may be domestic, international or Ministries of Health. Domestic academic institutions, community organizations, universities Eligible applicant types include: Unrestricted by Entity Type, Unrestricted by Individual Type. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Arthritis, Musculoskeletal and Skin Diseases Research - Training Individual (TR) is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; training of basic and clinical scientists to carry out this research; and dissemination of information on research progress in these diseases. The Extramural Program promotes and supports basic, translational, and clinical studies of Systemic Rheumatic and Autoimmune Diseases, Skin Biology and Diseases, Bone Biology and Diseases, Muscle Biology and Diseases, and Joint Biology and Diseases and Orthopaedics. NIAMS Systemic Rheumatic and Autoimmune Diseases programs address basic, translational, and clinical research, including clinical trials and observational and mechanistic studies, focused on immune-mediated arthritis and autoimmune-related acute and chronic disorders in adults and children. NIAMS Skin Biology and Diseases programs support basic, translational, and clinical research in skin, including both common and rare skin diseases. These programs include investigations of the basic molecular, cellular, and developmental biology of skin, as well as studies of skin as an immune, sensory, endocrine, and metabolic organ. NIAMS Bone Biology and Diseases programs support research on the control of bone formation, resorption, and mineralization as well as the effects of signaling molecules on bone cells. They support clinical studies of interventions to prevent fractures associated with osteoporosis and research into less common bone diseases. NIAMS Muscle Biology and Diseases programs encourage research on muscle developmental biology, growth, maintenance, and hypertrophy; physiology of contraction; structural biology of the contractile apparatus; disease mechanisms; biomarkers and outcome measures; and development and clinical testing of therapies for conditions including the muscular dystrophies. NIAMS Joint Biology, Diseases, and Orthopaedics programs support a broad spectrum of research centered on the interplay among the body’s muscles, bones, and connective tissues. They encourage tissue engineering and regenerative medicine research, molecular biology, imaging, and clinical research, and the treatment and prevention of orthopaedic conditions. This listing is currently active. Program number: 93.AR3. Last updated on 2026-01-28. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $3,765,000 (2026).; eligibility guidance Any candidate(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with their sponsor and organization to develop an application for support. Multiple PDs/PIs are not allowed. By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status). Eligible applicant types include: Unrestricted by Individual Type. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.